$4.35
-0.21-4.61%
Últ. Act.: Oct 30, 7:58 PM
Abeona Therapeutics (ABEO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.38 | $-0.36 | $-0.31 |
| Actual | $-0.35 | $-0.30 | $-0.34 | $-0.10 |
| Surprise | -45.8% | +21.1% | +5.56% | +67.7% |
| Revenue | ||||
| Estimate | $12.3M | $5.1M | $4.9M | $5.5M |
| Actual | $11.4M | $8.7M | $5.4M | $0 |
| Surprise | -7.79% | +72.0% | +10.2% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.16 | $-0.12 | $-0.02 | $0.04 |
| Revenue | ||||
| Consensus | $15.5M | $18.7M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.35 | $-0.24 | -45.8 % |
| Q1 | May 13, 2026 | $-0.30 | $-0.38 | 21.1 % |
| Q4 | Mar 17, 2026 | $-0.34 | $-0.36 | 5.56 % |
| Q3 | Nov 12, 2025 | $-0.10 | $-0.31 | 67.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $11.38M | $12.34M | -7.79 % |
| Q1 | May 13, 2026 | $8.72M | $5.07M | 72.0 % |
| Q4 | Mar 17, 2026 | $5.42M | $4.92M | 10.2 % |
| Q3 | Nov 12, 2025 | $0 | $5.49M | -100.0 % |